Mersana Therapeutics, Inc. Patent Applications Rejected
18 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-01-26: Application 18160012; Invention COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY; Applicant Mersana Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-10-26: Application 18049793; Invention MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF; Applicant Mersana Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-09-09: Application 17930924; Invention NaPi2b-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER; Applicant Mersana Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2022-06-28: Application 17851618; Invention NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF; Applicant Mersana Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-01-26 | 18160012 | COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230355787A1 | Rebecca MOSHER Laura L. POLING Donald A. BERGSTROM | United States United States United States | PUTTLITZ, KARL J |
| 2022-10-26 | 18049793 | MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230265197A1 | Natalya D. BODYAK Michael J. DEVIT Eric M. KRAULAND Timothy B. LOWINGER Peter U. PARK Bianka PRINZ Aleksandr V. YURKOVETSKIY | United States United States United States United States United States United States United States | GODDARD, LAURA B |
| 2022-09-09 | 17930924 | NaPi2b-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230338569A1 | Robert A. BURGER | United States | JEAN-LOUIS, SAMIRA JM |
| 2022-06-28 | 17851618 | NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220332815A1 | Eric P. HAILMAN Donna M. JARLENSKI Donald A. BERGSTROM | United States United States United States | VAN DRUFF, SYDNEY |
| 2022-06-06 | 17782796 | DIMERIC COMPOUNDS AS STING AGONISTS | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230074558A1 | Jeremy R. DUVALL Keith W. BENTLEY Ha Thi DO Brian D. JONES Nabeelah I. KAUSER Eugene W. KELLEHER Soumya S. RAY Joshua D. THOMAS Dorin TOADER Liping YANG | United States United States United States United States United States United States United States United States United States United States | HEITMEIER, KENDALL NICOLE |
| 2022-05-03 | 17735575 | COMBINATION THERAPY OF CARBOPLATIN AND NAPI2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220370631A1 | Robert A. BURGER | United States | ESSEX, LAURA ANN |
| 2021-04-02 | 17221341 | ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220378749A1 | Jeremy R. DUVALL Keith W. BENTLEY Raghida A. BUKHALID Naniye CETINBAS Marc I. DAMELIN Eugene W. KELLEHER Timothy B. LOWINGER Joshua D. THOMAS Dorin TOADER Ling XU Liping YANG | United States United States United States United States United States United States United States United States United States United States United States | SKOKO III, JOHN JOSEPH |
| 2021-01-20 | 17153711 | NAPI2B-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210301031A1 | Donald A. BERGSTROM Natalya D. BODYAK Timothy B. LOWINGER Peter U. PARK Laura L. POLING Aleksandr V. YURKOVETSKIY | United States United States United States United States United States United States | CANELLA, KAREN A |
| 2020-06-18 | 16955346 | PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES | Mersana Therapeutics, Inc. | Abandoned -- Failure to Pay Issue Fee | US20220305127A1 | Joshua D. THOMAS Brian D. JONES Eugene W. KELLEHER Timothy B. LOWINGER Liping YANG Mao YIN Aleksandr V. YURKOVETSKIY | United States United States United States United States United States United States United States | KOSACK, JOSEPH R |
| 2020-01-23 | 16750246 | PROTEIN-POLYMER-DRUG CONJUGATES | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210106690A1 | Aleksandr V. YURKOVETSKIY Mao YIN Timothy B. LOWINGER Joshua D. THOMAS Charles E. HAMMOND Cheri A. STEVENSON Natalya D. BODYAK Patrick R. CONLON Dmitry R. GUMEROV | United States United States United States United States United States United States United States United States United States | COFFA, SERGIO |
| 2017-11-16 | 15814914 | PROTEIN-POLYMER-DRUG CONJUGATES | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180140716A1 | Aleksandr V. YURKOVETSKIY Mao YIN Timothy B. LOWINGER Joshua D. THOMAS Cheri A. STEVENSON Venu Reddy GURIJALA | United States United States United States United States United States United States | HIRT, ERIN E |
| 2017-09-15 | 15705828 | TUBULYSIN COMPOUNDS AND CONJUGATES THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20180243427A1 | Aleksandr V. YURKOVETSKIY Timothy B. LOWINGER | United States United States | WHEELER, THURMAN MICHAEL |
| 2017-07-14 | 15650429 | MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170313778A1 | Natalya D. BODYAK Michael J. DeVIT Eric M. KRAULAND Timothy B. LOWINGER Peter U. PARK Bianka PRINZ Aleksandr V. YURKOVETSKIY | United States United States United States United States United States United States United States | GODDARD, LAURA B |
| 2016-09-08 | 15260084 | TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170119896A1 | Aleksandr V. Yurkovetskiy Venu R. Gurijala Joshua D. Thomas Timothy B. Lowinger | United States United States United States United States | LAZARO, DOMINIC |
| 2015-09-14 | 14776449 | TUBULYSIN COMPOUNDS AND CONJUGATES THEREOF | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20160022829A1 | Aleksandr V. Yurkovetskiy Timothy B. Lowinger | United States United States | WHEELER, THURMAN MICHAEL |
| 2013-07-03 | 13934931 | Terminally Modified Polymers and Conjugates Thereof | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140017265A1 | Aleksandr V. Yurkovetskiy Venu R. Gurijala Joshua D. Thomas Timothy B. Lowinger | United States United States United States United States | LAZARO, DOMINIC |
| 2013-06-18 | 13920749 | Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer Conjugates | Mersana Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140004074A1 | James Rolke Russell C. Petter Mao Yin Aleksandr V. Yurkovetskiy Gui Liu Emile Farhan | United States United States United States United States United States United States | FALKOWITZ, ANNA R |
| 2013-01-07 | 13735872 | Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use Thereof | MERSANA THERAPEUTICS, INC. | Abandoned -- Failure to Respond to an Office Action | US20130109817A1 | Aleksandr V. Yurkovetskiy Mao Yin Timothy B. Lowinger Carolina B. Cabral Charles E. Hammond Cheri A. Stevenson | United States United States United States United States United States United States | SCHNIZER, RICHARD A |